NCT00120679View on ClinicalTrials.gov

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

December 31, 2003

Conditions
Non-Small Cell Lung CancerAnemia
Interventions
DRUG

darbepoetin alfa

DRUG

recombinant human erythropoietin (rHuEPO)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00120679 - Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy | Biotech Hunter | Biotech Hunter